The mechanisms of protection were the lowering of fasting hyperglycemia, the attenuation of hepatic gluconeogenesis and dyslipidemia, the activation of Nrf2, the upregulation of antioxidants, and the suppression of NF-κβ and inflammatory cytokine production [27]. The gene discussed is NFKB1; the disease is Hyperglycemia.